August 01, 2005

Drug company influence causes scientific split

A group of high blood pressure researchers is ending its 16-year relationship with a high blood pressure journal, and claims of improper drug company influence on doctors are at the root of the dispute.

The Wall Street Journal has details.

Dr. John Laragh, co-founder of the American Journal of Hypertension, complains that some doctors have become "heavily involved in pharma marketing for personal gain."

As the Journal appropriately frames the story, it is "a dispute reflecting heightened concerns about the control and credibility of medical information."

Posted by schwitz at August 1, 2005 09:18 AM | TrackBack
Comments
The views and opinions expressed in this page are strictly those of the page author. The contents of this page have not been reviewed or approved by the University of Minnesota.